Science · 3 September 2026 · From issue 32
(Un)intended consequences of mass-prescribing GLP-1s
Fair access to popular weight loss drugs faces threats from competing business interests.
Luc L. Hagenaars, Laura A. Schmidt.
The World Health Organization now tells countries to use a class of weight loss drugs to treat obesity. These drugs also get used for skin problems, sexual issues, and addiction. WHO wants fair access for the 1 billion people worldwide who have obesity. But drug makers, food companies, and wellness brands are all racing to cash in, which could make fair access harder to reach.
Integrity screen: passed (3 checks) Checked 10 September 2026. Read the source
The plain-language reading of this paper is in the full issue, for subscribers.
Read the full issue